Literature DB >> 10408692

Telomerase activity in melanoma and non-melanoma skin cancer.

C N Parris1, S Jezzard, A Silver, R MacKie, J M McGregor, R F Newbold.   

Abstract

Telomeres are specialized structures consisting of repeat arrays of TTAGGGn located at the ends of chromosomes. They are essential for chromosome stability and, in the majority of normal somatic cells, telomeres shorten with each cell division. Most immortalized cell lines and tumours reactivate telomerase to stabilize the shortening chromosomes. Telomerase activation is regarded as a central step in carcinogenesis and, here, we demonstrate telomerase activation in premalignant skin lesions and also in all forms of skin cancer. Telomerase activation in normal skin was a rare event, and among 16 samples of normal skin (one with a history of chronic sun exposure) 12.5% (2 out of 16) exhibited telomerase activity. One out of 16 (6.25%) benign proliferative lesions, including viral and seborrhoeic wart samples, had telomerase activity. In premalignant actinic keratoses and Bowen's disease, 42% (11 out of 26) of samples exhibited telomerase activity. In the basal cell carcinoma and cutaneous malignant melanoma (CMM) lesions, telomerase was activated in 77% (10 out of 13) and 69% (22 out of 32) respectively. However, only 25% (3 out of 12) of squamous cell carcinomas (SCC) had telomerase activity. With the exception of one SCC sample, telomerase activity in a positive control cell line derived from a fibrosarcoma (HT1080) was not inhibited when mixed with the telomerase-negative SCC or CMM extracts, indicating that, overall, Taq polymerase and telomerase inhibitors were not responsible for the negative results. Mean telomere hybridizing restriction fragment (TRF) analysis was performed in a number of telomerase-positive and -negative samples and, although a broad range of TRF sizes ranging from 3.6 to 17 kb was observed, a relationship between telomerase status and TRF size was not found.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10408692      PMCID: PMC2362177          DOI: 10.1038/sj.bjc.6690010

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  The Stability of Broken Ends of Chromosomes in Zea Mays.

Authors:  B McClintock
Journal:  Genetics       Date:  1941-03       Impact factor: 4.562

2.  Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes.

Authors:  C Härle-Bachor; P Boukamp
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  Evidence for UV-associated activation of telomerase in human skin.

Authors:  M Ueda; A Ouhtit; T Bito; K Nakazawa; J Lübbe; M Ichihashi; H Yamasaki; H Nakazawa
Journal:  Cancer Res       Date:  1997-02-01       Impact factor: 12.701

4.  Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.

Authors:  J F Flores; G J Walker; J M Glendening; F G Haluska; J S Castresana; M P Rubio; G C Pastorfide; L A Boyer; W H Kao; M L Bulyk; R L Barnhill; N K Hayward; D E Housman; J W Fountain
Journal:  Cancer Res       Date:  1996-11-01       Impact factor: 12.701

Review 5.  Telomeres, telomerase, and immortality.

Authors:  M S Rhyu
Journal:  J Natl Cancer Inst       Date:  1995-06-21       Impact factor: 13.506

6.  Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines.

Authors:  T M Bryan; A Englezou; L Dalla-Pozza; M A Dunham; R R Reddel
Journal:  Nat Med       Date:  1997-11       Impact factor: 53.440

7.  DNA methylation changes in the IL-1 (2F) chromosomal region of some radiation-induced acute myeloid leukaemias carrying chromosome 2 rearrangements.

Authors:  A Silver; A George; W Masson; G Breckon; J Adam; R Cox
Journal:  Genes Chromosomes Cancer       Date:  1991-09       Impact factor: 5.006

8.  Telomerase activity in normal and malignant hematopoietic cells.

Authors:  D Broccoli; J W Young; T de Lange
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

9.  Detection of telomerase activity in malignant and nonmalignant skin conditions.

Authors:  R S Taylor; R D Ramirez; M Ogoshi; M Chaffins; M A Piatyszek; J W Shay
Journal:  J Invest Dermatol       Date:  1996-04       Impact factor: 8.551

10.  Telomere dynamics in an immortal human cell line.

Authors:  J P Murnane; L Sabatier; B A Marder; W F Morgan
Journal:  EMBO J       Date:  1994-10-17       Impact factor: 11.598

View more
  12 in total

1.  Cancer Immune Equilibrium and Schizophrenia Have Similar Interferon-γ, Tumor Necrosis Factor-α, and Interleukin Expression: A Tumor Model of Schizophrenia.

Authors:  James S Brown
Journal:  Schizophr Bull       Date:  2016-05-11       Impact factor: 9.306

2.  Combined analysis of cell growth and apoptosis-regulating proteins in HPVs associated anogenital tumors.

Authors:  Tsuyoshi Mitsuishi; Yukie Iwabu; Kenzo Tokunaga; Tetsutaro Sata; Takehiko Kaneko; Kuniaki Ohara; Ikuroh Ohsawa; Fumino Oda; Yuko Yamada; Seiji Kawana; Kohji Ozaki; Mayuka Nakatake; Osamu Yamada
Journal:  BMC Cancer       Date:  2010-03-27       Impact factor: 4.430

3.  Correlation of telomere length to malignancy potential in non-melanoma skin cancers.

Authors:  Hanae Yamada-Hishida; Yoshimasa Nobeyama; Hidemi Nakagawa
Journal:  Oncol Lett       Date:  2017-10-26       Impact factor: 2.967

4.  Squamous cell carcinoma of the skin: Emerging need for novel biomarkers.

Authors:  Atte Kivisaari; Veli-Matti Kähäri
Journal:  World J Clin Oncol       Date:  2013-11-10

Review 5.  Telomerase promoter mutations in cancer: an emerging molecular biomarker?

Authors:  João Vinagre; Vasco Pinto; Ricardo Celestino; Marta Reis; Helena Pópulo; Paula Boaventura; Miguel Melo; Telmo Catarino; Jorge Lima; José Manuel Lopes; Valdemar Máximo; Manuel Sobrinho-Simões; Paula Soares
Journal:  Virchows Arch       Date:  2014-07-22       Impact factor: 4.064

6.  Construction of neocentromere-based human minichromosomes by telomere-associated chromosomal truncation.

Authors:  R Saffery; L H Wong; D V Irvine; M A Bateman; B Griffiths; S M Cutts; M R Cancilla; A C Cendron; A J Stafford; K H Choo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

7.  Telomerase detection in the diagnosis and prognosis of cancer.

Authors:  Eiso Hiyama; Keiko Hiyama
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

8.  Absence of telomerase activity and telemorase catalytic subunit mRNA in melanocyte cultures.

Authors:  K Dhaene; G Vancoillie; J Lambert; J M Naeyaert; E Van Marck
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

9.  The secreted protein S100A7 (psoriasin) is induced by telomere dysfunction in human keratinocytes independently of a DNA damage response and cell cycle regulators.

Authors:  Alice de Castro; Fay Minty; Eva Hattinger; Ronald Wolf; Eric Kenneth Parkinson
Journal:  Longev Healthspan       Date:  2014-10-17

10.  Unusually stable abnormal karyotype in a highly aggressive melanoma negative for telomerase activity.

Authors:  Sarantis Gagos; George Papaioannou; Maria Chiourea; Sophie Merk-Loretti; Charles-Edward Jefford; Panagiota Mikou; Irmgard Irminger-Finger; Anna Liossi; Jean-Louis Blouin; Sophie Dahoun
Journal:  Mol Cytogenet       Date:  2008-08-22       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.